SB 150 - AS INTRODUCED
SENATE BILL 150
SPONSORS: Sen. Soucy, Dist 18; Sen. Reagan, Dist 17; Rep. M. MacKay, Hills. 30; Rep. Guthrie, Rock. 13; Rep. LeBrun, Hills. 32
COMMITTEE: Health and Human Services
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Seventeen
Be it Enacted by the Senate and House of Representatives in General Court convened:
318:16-b Pharmacist Administration of Vaccines. A pharmacist or pharmacy intern under the direct supervision of an immunizing pharmacist may administer influenza vaccines to the general public and a pharmacist or pharmacy intern may administer pneumococcal and varicella zoster vaccines to individuals 18 years of age or older, provided all of the criteria in this section have been met. The pharmacist and pharmacy intern shall:
I. Hold a current license to practice as a pharmacist or be registered as a pharmacy intern under RSA 318:15-b in New Hampshire.
II. Possess at least $1,000,000 of professional liability insurance coverage.
III. In order to administer influenza, pneumococcal, and varicella zoster vaccines, have completed training specific to the administering of the respective vaccines that includes programs approved by the Accreditation Council for Pharmacy Education (ACPE) or curriculum-based programs from an ACPE-accredited college of pharmacy or state or local health department programs or programs recognized by the board.
IV. Provide to the board evidence of compliance with paragraphs I-III.
V. Provide notice to the primary care provider, when designated by the patient, of the administration of the pneumococcal and varicella zoster vaccines.
VI. Maintain a record of administration of pneumococcal and varicella zoster vaccinations for each individual as required by state and federal law.
|Jan. 19, 2017||Introduced 01/19/2017 and Referred to Health and Human Services; SJ 5|
|March 14, 2017||==CANCELLED== Hearing: 03/14/2017, Room 101, LOB, 01:45 pm; SC 14|
|March 20, 2017||Hearing: 03/20/2017, Room 101, LOB, 09:45 am; SC 15|
|March 29, 2017||Committee Report: Ought to Pass, 03/29/2017; SC 16|
|March 29, 2017||Ought to Pass: MA, VV; OT3rdg; 03/29/2017; SJ 11|
|March 23, 2017||Introduced 03/23/2017 and referred to Health, Human Services and Elderly Affairs HJ 11 P. 27|
|April 11, 2017||Public Hearing: 04/11/2017 01:00 PM LOB 205|
|April 11, 2017||Executive Session: 04/11/2017 LOB 205|
|April 20, 2017||Committee Report: Ought to Pass for 04/20/2017 (Vote 13-0; CC) HC 20 P. 5|
|April 20, 2017||Ought to Pass: MA VV 04/20/2017 HJ 14 P. 6|
|April 20, 2017||Enrolled 04/20/2017 HJ 14 P. 26|
|April 27, 2017||Enrolled (In recess 04/27/2017); SJ 16|
|July 11, 2017||Signed by the Governor on 05/12/2017; Chapter 0051; Effective 07/11/2017|
|March 20, 2017||Senate||Hearing|
|March 29, 2017||Senate||Floor Vote|
|April 11, 2017||House||Hearing|
|April 11, 2017||House||Exec Session|
|April 20, 2017||House||Floor Vote|